Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Zobel, A. W. Articles by Holsboer, F. Search for Related Content PubMed Citation Articles by Zobel, A. W. Articles by Holsboer, F. Neuroendocrinology Depression

Prediction of Medium-Term Outcome by Cortisol Response to the Combined Dexamethasone-CRH Test in Patients With Remitted Depression

OBJECTIVE: Current hypotheses hold that mechanisms underlying abnormal hypothalamic-pituitary-adrenocortical (HPA) function are causal factors in the precipitation of depression. If this is the case, then normalization of initially disturbed HPA regulation should indicate a good prognosis and persistent HPA dysregulation should be associated with a greater likelihood of relapse or chronicity. METHOD: The combined dexamethasone/corticotropin-releasing hormone test was administered twice to inpatients with major depression (N=40), once after initiation of treatment and once after remission, shortly before discharge. RESULTS: Patients with a high cortisol response on both occasions or with a substantially increased cortisol response at discharge were at much higher risk for relapse within the next 6 months than those with low cortisol responses. CONCLUSIONS: An easy-to-administer neuroendocrine test allows the prediction of medium-term outcome in patients with remitted depression.

This article has been cited by other articles:

				T. Ahrens, M. Deuschle, B. Krumm, G. van der Pompe, J. A. den Boer, and F. Lederbogen Pituitary-Adrenal and Sympathetic Nervous System Responses to Stress in Women Remitted From Recurrent Major Depression Psychosom Med, May 1, 2008; 70(4): 461 - 467. [Abstract] [Full Text] [PDF]

				C. M. Pariante The glucocorticoid receptor: part of the solution or part of the problem? J Psychopharmacol, July 1, 2006; 20(4 Suppl): 79 - 84. [Abstract] [PDF]

				K. Putnam, G. P. Chrousos, L. K. Nieman, and D. R. Rubinow Sex-Related Differences in Stimulated Hypothalamic-Pituitary-Adrenal Axis during Induced Gonadal Suppression J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4224 - 4231. [Abstract] [Full Text] [PDF]

				S. Ridder, S. Chourbaji, R. Hellweg, A. Urani, C. Zacher, W. Schmid, M. Zink, H. Hortnagl, H. Flor, F. A. Henn, et al. Mice with Genetically Altered Glucocorticoid Receptor Expression Show Altered Sensitivity for Stress-Induced Depressive Reactions J. Neurosci., June 29, 2005; 25(26): 6243 - 6250. [Abstract] [Full Text] [PDF]

				S. L. King and K. M. Hegadoren Stress Hormones: How Do They Measure Up? Biol Res Nurs, October 1, 2002; 4(2): 92 - 103. [Abstract] [PDF]

				Z. BHAGWAGAR, R. WHALE, and P. J. COWEN State and trait abnormalities in serotonin function in major depression The British Journal of Psychiatry, January 1, 2002; 180(1): 24 - 28. [Abstract] [Full Text] [PDF]

				R. McQUADE and A. H. Y. YOUNG Future therapeutic targets in mood disorders: the glucocorticoid receptor The British Journal of Psychiatry, November 1, 2000; 177(5): 390 - 395. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 1999 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us